Company Filing History:
1 out of 23 
1 out of 5 Years Active: 2025
Title: Ji-Eun Cha: Innovator in Growth Hormone Treatment
Introduction
Ji-Eun Cha is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of growth hormone deficiency. His innovative approach has led to the development of a unique method that utilizes a human growth hormone fusion protein.
Latest Patents
Ji-Eun Cha holds a patent for a method for treating growth hormone deficiency employing a human growth hormone fusion protein known as GX-H9. This method involves administering a pharmaceutical composition containing the hGH fusion protein, which can be given to pediatric patients either weekly or bi-weekly, depending on their weight.
Career Highlights
Throughout his career, Ji-Eun Cha has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Genexine, Inc. and Handok Inc., where he has contributed to advancements in medical treatments and therapies.
Collaborations
Ji-Eun Cha has collaborated with various professionals in his field, including his coworker Jung Won Woo, who has also played a role in the development of innovative medical solutions.
Conclusion
Ji-Eun Cha's work in the field of growth hormone treatment exemplifies the impact of innovation in medicine. His contributions continue to pave the way for advancements in healthcare and improve the lives of pediatric patients suffering from growth hormone deficiency.